RNA sequencing can contribute to the development of a reliable drug recommendation tool

October 12, 2018 Leave a comment 2,371 Views

A new precision medicine platform utilizing both DNA and RNA sequencing helps identify targeted therapy options for patients with relapsed or refractory multiple myeloma. Multiple myeloma (MM) is a malignancy of plasma cells, with a median survival...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Icahn School of Medicine Mount Sinai

RNA sequencing can contribute to the development of a reliable drug recommendation tool

Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression

ICRNASA 2022 – International Conference on RNA Sequencing and Analysis

New data suggest he percepta GSC RNA sequencing-based risk-stratification test can help accelerate timely treatment for patients with early-stage lung cancer

Quick determination of RNA-Seq strandedness

Benchmarking of a Bayesian single cell RNAseq differential gene expression test for dose–response study designs

Massively parallel direct RNA sequencing enables scientists to build ‘valves’ in DNA to shape biological information flows

Featured RNA-Seq Job – Research Associate/Senior Research Associate (Single Cell RNA Sequencing Library Preparation)